Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
900
Trial Sponsor
Clinical Trial Start Date
April 22, 2024
0Primary Completion Date
January 1, 2025
0Study Completion Date
May 1, 2025
0Clinical Trial Study Type
Observational0
Intervention Type
Drug0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
Salivary MicroRNA in Endometriosis: Correlation With Progestin Treatment Response: A Prospective Observational Study0
Last Updated
May 15, 2024
0Other attributes
Intervention Treatment
Dienogest 2 MG0
Study summary
This study aims to analyze the salivary miRNA specific for patients diagnosed with endometriosis, specifically evaluating the miRNA profile of patients who respond versus those who do not respond to progestin therapy. Ninety patients attending the Chronic Pelvic Pain Clinic will be recruited, and they will be asked to provide a saliva sample before starting medical therapy. The response to the therapy will be evaluated after 4 months from the beginning of the therapy itself.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
